Lv11
30 积分 2024-08-29 加入
Allogeneic CD19-targeted CAR-T therapy in refractory systemic lupus erythematosus achieved durable remission
5小时前
已完结
Universal CAR T Cells Treat Leukemia
2个月前
已完结
CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up
2个月前
已完结
Anti-BCMA/GPRC5D bispecific CAR T cells for relapsed or refractory multiple myeloma: is 1 + 1 greater than 2?
3个月前
已完结
Synergistic Integration of mRNA-LNP with CAR-Engineered Immune Cells: Pioneering Progress in Immunotherapy
3个月前
已完结
T-cell engineering by a chimeric T-cell receptor with antibody-type specificity for the HIV-1 gp120
3个月前
已完结
Reservoirs for HIV-1: Mechanisms for Viral Persistence in the Presence of Antiviral Immune Responses and Antiretroviral Therapy
3个月前
已完结
Cellular immunity to HIV activated by CD4 fused to T cell or Fc receptor polypeptides
3个月前
已完结
Stress, social support, and the buffering hypothesis
4个月前
已完结
A comprehensive review on the role of T cell subsets and CAR-T cell therapy in Aspergillus fumigatus infection
4个月前
已关闭
皖公网安备34019202002308
